SCHEMBL10094278

SCHEMBL10094278

CC(C)c1cccnc1Nc1ccc(OC(F)(F)F)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 2/20 0.60
▸ P2RY2 P41231 1/20 0.52
▸ P2RY1 P47900 1/20 0.52
▸ P2RY14 Q15391 1/20 0.52
▸ TRPV1 Q8NER1 1/20 0.48
▸ ABL1 P00519 5/20 0.46
▸ BCR P11274 5/20 0.46
▸ EPHX2 P34913 1/20 0.46
▸ CTSC P53634 1/20 0.45
▸ TTBK1 Q5TCY1 1/20 0.45
▸ TTBK2 Q6IQ55 1/20 0.45
▸ ALDH1A1 P00352 2/20 0.45
▸ NPC1 O15118 1/20 0.45
▸ POLB P06746 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ KDR P35968 1/20 0.44
▸ KCNH2 Q12809 1/20 0.42
▸ SCN5A Q14524 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10094192 0.80 DHODH (0.54) DHODHALDH1A1NPC1POLBHPGD
SCHEMBL22543353 0.79 DHODH (0.62) DHODHABL1BCREPHX2CTSC
SCHEMBL10094191 0.78 DHODH (0.51) DHODHALDH1A1NPC1POLBHPGD
SCHEMBL10094254 0.77 RAB9A (0.54) DHODHALDH1A1NPC1POLBHPGD
SCHEMBL20553261 0.77 HPGD (0.63) DHODHABL1BCREPHX2CTSC
SCHEMBL10094180 0.76 NPC1 (0.47) DHODHALDH1A1NPC1POLBHPGD
SCHEMBL10094291 0.75 CDC25B (0.51) ALDH1A1NPC1POLBHPGDRAB9A
SCHEMBL10094295 0.74 ABCG2 (0.50) —
SCHEMBL10094260 0.74 ADRA2A (0.45) ALDH1A1NPC1POLBHPGDRAB9A
SCHEMBL2739344 0.74 LMNA (0.64) DHODHTRPV1CTSCALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148535-B2 Potassium channel inhibitors MERCK SHARP & DOHME CORP. (US) 2012-04-03 — — US disclosed
US-8148535-B2 Potassium channel inhibitors MERCK SHARP & DOHME CORP. (US) 2012-04-03 — — US disclosed
US-20090233897-A1 Potassium Channel Inhibitors MERCK SHARP & DOHME CORP. 2009-09-17 — — US disclosed
US-20090233897-A1 Potassium Channel Inhibitors MERCK SHARP & DOHME CORP. 2009-09-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090233897-A1 Potassium Channel Inhibitors KCNJ2, KCNQ2, KCNH2 DHODH 1364/4885P2RY2 399/4885P2RY1 513/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback